ENDRA Life Sciences Inc. announces a new European patent that strengthens its TAEUS® platform for monitoring tissue temperature.
Nov 06, 2024
Ann ArborManufacturingBiotechnologyHealth CareMedicalMedical DeviceHealth Diagnostics
Product Description
ENDRA Life Sciences Inc. has announced the issuance of its 17th European patent related to the TAEUS® platform, a method for monitoring tissue temperature during minimally invasive thermal surgical interventions. This patent enhances the company's intellectual property and supports its strategy to develop advanced ultrasound and thermoacoustic imaging systems.
Company Information
Company
ENDRA Life Sciences
Location
Ann Arbor, Michigan, United States
About
ENDRA Life Sciences is the pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), a ground-breaking technology being developed to visualize tissue like MRI, but at 1/50th the cost and at the point of patient care. TAEUS® is designed to work in concert with 400,000 cart-based ultrasound systems in use globally today. TAEUS® is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and inflammation (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, ENDRA is exploring several other clinical applications of TAEUS®, including visualization of tissue temperature during energy-based surgical procedures. For more information, please visit www.endrainc.com.
Fundz sees it the moment ENDRA Life Sciences ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Ann ArborManufacturingBiotechnologyHealth CareMedicalMedical DeviceHealth Diagnostics